A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a Novel Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Hospitalized Adults

  • Hanfelt-Goade, D.; 
  • Maimon, N.; 
  • Nimer, A.; 
  • Riviere, F.; 
  • Catherinot, E.; 
  • ... Jeong, S.; 
  • 외 21명
Citations

WEB OF SCIENCE

17
제목
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a Novel Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Hospitalized Adults
저자
Hanfelt-Goade, D.; Maimon, N.; Nimer, A.; Riviere, F.; Catherinot, E.; Ison, M.; Jeong, S.; Walsh, E.; Gafter-Gvili, A.; Nama, S.; Napora, P.; Chowers, M.; Bergeron, A.; Zeltser, D.; Moudgil, H.; Limaye, A. P.; Couturaud, F.; Nseir, W.; McKevitt, M.; Porter, D.; Jordan, R.; Guo, Y.; German, P.; Watkins, T. R.; Gossage, D. L.; Chien, J. W.; Falsey, A. R.
발행일
2018-05
유형
Meeting Abstract
저널명
American Journal of Respiratory and Critical Care Medicine
권
197